Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Karah Herdman Parschauer currently holds 49,960 shares of Ultragenyx Pharmaceutical Inc. (RARE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karah Herdman Parschauer has been a net seller of RARE stock. They have purchased $0 and sold $9.7M worth of shares.
Karah Herdman Parschauer's most recent insider trade was on Apr 16, 2026, when they sold 49,960 shares at $0.00 per share.
Karah Herdman Parschauer serves as Executive at Ultragenyx Pharmaceutical Inc. (RARE). They have executed 77 insider transactions totaling $9.7M over their tenure at the company.
Karah Herdman Parschauer holds the position of Executive at Ultragenyx Pharmaceutical Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Karah Herdman Parschauer has shown a selling trading pattern, with $0 in total purchases and $9.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Karah Herdman Parschauer was on Oct 30, 2020, when they sold $991.5K worth of RARE shares. This transaction involved 9,903 shares at $100.12 per share.
Karah Herdman Parschauer currently owns 49,960 shares of Ultragenyx Pharmaceutical Inc. (RARE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Karah Herdman Parschauer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Karah Herdman Parschauer has 77 Form 4 filings on record as an insider at Ultragenyx Pharmaceutical Inc..
Set alerts for Karah Herdman Parschauer and 40,000+ other insiders.